Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04030507 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

StatusActive, Not Recruiting
PhaseNot applicable
Started2019-07-26
View on ClinicalTrials.gov ↗

Amendment history

2026-09-04
Study Status, Contacts/Locations v9
Enrollment closed, study ongoing
Study sitesdetails revised at 1 of 1 site
2026-03-17
Study Identification, Study Status, Sponsor/Collaborators v8
Primary completion date2025-02→2027-02
Completion date2026-02→2028-02
Lead sponsorDana-Farber Cancer Institute→Brigham and Women's Hospital
Collaborators1 to 2 entries
Dana-Farber Cancer Institute
2024-10-22
Study Status v7
Re-verified, no change to tracked fields
2023-09-21
Study Status, Contacts/Locations v6
Primary completion date2024-02→2025-02
Completion date2025-02→2026-02
2022-12-09
Study Status v5
Primary completion date2022-09-21→2024-02
Completion date2023-07-01→2025-02
Show 4 earlier versions
2022-07-19
Study Status v4
Primary completion date2022-07-01→2022-09-21
2021-05-18
2 amendments v2-v3
2 re-verifications since 2020-12-22, no change to tracked fields
2019-11-18
Not Yet Recruiting→Recruiting Study Identification, Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2019-07-31→confirmed 2019-07-26
Study sitesdetails revised at 1 of 1 site
2019-07-22
Original filing
This research study is studying the usefulness of magnetic resonance imaging (MRI) to screen for brain metastases (spread of the breast cancer to the brain).
Trial Details
NCT Number NCT04030507
Lead Sponsor Brigham and Women's Hospital
Collaborators: Conquer Cancer Foundation, Dana-Farber Cancer Institute
Conditions Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Inflammatory Breast Cancer, Metastatic Breast Cancer
Enrollment 214 participants
Start Date 2019-07-26
Primary Completion 2027-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-09-09